The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropeniaLionel D. Lewis, Mark J. Ratain, Antonius A. Miller et al.|Pharmacogenetics and Genomics|2012Cited by 27
A population pharmacokinetic model based on HPTN 077 of long‐acting injectable cabotegravir for HIV PrEPYifan Yu, Kristin L. Bigos, Mark A. Marzinke et al.|British Journal of Clinical Pharmacology|2022Cited by 11
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance)Howard L. McLeod, Antonius A. Miller, Kouros Owzar et al.|eScholarship (California Digital Library)|2020Cited by 3
A Population Pharmacokinetic Model Based on HPTN 077 of Long-acting Injectable Cabotegravir for HIV PrEPYifan Yu, Ethel D. Weld, Kristi Bigos et al.|Unknown|2022Cited by 2
Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083Brett Hanscom, Raphael J. Landovitz, Mark A. Marzinke et al.|The Journal of Infectious Diseases|2025Cited by 2